-
Je něco špatně v tomto záznamu ?
Does PAD and microcirculation status impact the tissue availability of intravenously administered antibiotics in patients with infected diabetic foot? Results of the DFIATIM substudy
V. Fejfarová, R. Jarošíková, S. Antalová, J. Husáková, V. Wosková, P. Beca, J. Mrázek, P. Tůma, J. Polák, M. Dubský, D. Sojáková, V. Lánská, M. Petrlík
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- antibakteriální látky * farmakokinetika aplikace a dávkování terapeutické užití MeSH
- diabetická noha * farmakoterapie metabolismus MeSH
- intravenózní podání MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrocirkulace * účinky léků MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS/HYPOTHESIS: The aim of this substudy (Eudra CT No:2019-001997-27)was to assess ATB availability in patients with infected diabetic foot ulcers(IDFUs)in the context of microcirculation and macrocirculation status. METHODS: For this substudy, we enrolled 23 patients with IDFU. Patients were treated with boluses of amoxicillin/clavulanic acid(AMC)(12patients) or ceftazidime(CTZ)(11patients). After induction of a steady ATB state, microdialysis was performed near the IDFU. Tissue fluid samples from the foot and blood samples from peripheral blood were taken within 6 hours. ATB potential efficacy was assessed by evaluating the maximum serum and tissue ATB concentrations(Cmax and Cmax-tissue)and the percentage of time the unbound drug tissue concentration exceeds the minimum inhibitory concentration (MIC)(≥100% tissue and ≥50%/60% tissue fT>MIC). Vascular status was assessed by triplex ultrasound, ankle-brachial and toe-brachial index tests, occlusive plethysmography comprising two arterial flow phases, and transcutaneous oxygen pressure(TcPO2). RESULTS: Following bolus administration, the Cmax of AMC was 91.8 ± 52.5 μgmL-1 and the Cmax-tissue of AMC was 7.25 ± 4.5 μgmL-1(P<0.001). The Cmax for CTZ was 186.8 ± 44.1 μgmL-1 and the Cmax-tissue of CTZ was 18.6 ± 7.4 μgmL-1(P<0.0001). Additionally, 67% of patients treated with AMC and 55% of those treated with CTZ achieved tissue fT>MIC levels exceeding 50% and 60%, respectively. We observed positive correlations between both Cmax-tissue and AUCtissue and arterial flow. Specifically, the correlation coefficient for the first phase was r=0.42; (P=0.045), and for the second phase, it was r=0.55(P=0.01)and r=0.5(P=0.021). CONCLUSIONS: Bactericidal activity proved satisfactory in only half to two-thirds of patients with IDFUs, an outcome that appears to correlate primarily with arterial flow.
Department of Hygiene 3rd Faculty of Medicine Charles University Prague Czechia
Department of Internal Medicine 2nd Faculty of Medicine Charles University Prague Czechia
Department of Pathophysiology 3rd Faculty of Medicine Charles University Prague Czechia
Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czechia
Vascular and Internal Medicine Outpatient Clinic Prague Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013987
- 003
- CZ-PrNML
- 005
- 20240905134123.0
- 007
- ta
- 008
- 240725e20240507sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2024.1326179 $2 doi
- 035 __
- $a (PubMed)38774229
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Fejfarová, Vladimíra $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czechia
- 245 10
- $a Does PAD and microcirculation status impact the tissue availability of intravenously administered antibiotics in patients with infected diabetic foot? Results of the DFIATIM substudy / $c V. Fejfarová, R. Jarošíková, S. Antalová, J. Husáková, V. Wosková, P. Beca, J. Mrázek, P. Tůma, J. Polák, M. Dubský, D. Sojáková, V. Lánská, M. Petrlík
- 520 9_
- $a AIMS/HYPOTHESIS: The aim of this substudy (Eudra CT No:2019-001997-27)was to assess ATB availability in patients with infected diabetic foot ulcers(IDFUs)in the context of microcirculation and macrocirculation status. METHODS: For this substudy, we enrolled 23 patients with IDFU. Patients were treated with boluses of amoxicillin/clavulanic acid(AMC)(12patients) or ceftazidime(CTZ)(11patients). After induction of a steady ATB state, microdialysis was performed near the IDFU. Tissue fluid samples from the foot and blood samples from peripheral blood were taken within 6 hours. ATB potential efficacy was assessed by evaluating the maximum serum and tissue ATB concentrations(Cmax and Cmax-tissue)and the percentage of time the unbound drug tissue concentration exceeds the minimum inhibitory concentration (MIC)(≥100% tissue and ≥50%/60% tissue fT>MIC). Vascular status was assessed by triplex ultrasound, ankle-brachial and toe-brachial index tests, occlusive plethysmography comprising two arterial flow phases, and transcutaneous oxygen pressure(TcPO2). RESULTS: Following bolus administration, the Cmax of AMC was 91.8 ± 52.5 μgmL-1 and the Cmax-tissue of AMC was 7.25 ± 4.5 μgmL-1(P<0.001). The Cmax for CTZ was 186.8 ± 44.1 μgmL-1 and the Cmax-tissue of CTZ was 18.6 ± 7.4 μgmL-1(P<0.0001). Additionally, 67% of patients treated with AMC and 55% of those treated with CTZ achieved tissue fT>MIC levels exceeding 50% and 60%, respectively. We observed positive correlations between both Cmax-tissue and AUCtissue and arterial flow. Specifically, the correlation coefficient for the first phase was r=0.42; (P=0.045), and for the second phase, it was r=0.55(P=0.01)and r=0.5(P=0.021). CONCLUSIONS: Bactericidal activity proved satisfactory in only half to two-thirds of patients with IDFUs, an outcome that appears to correlate primarily with arterial flow.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a diabetická noha $x farmakoterapie $x metabolismus $7 D017719
- 650 12
- $a mikrocirkulace $x účinky léků $7 D008833
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a antibakteriální látky $x farmakokinetika $x aplikace a dávkování $x terapeutické užití $7 D000900
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a intravenózní podání $7 D061605
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jarošíková, Radka $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czechia
- 700 1_
- $a Antalová, Simona $u Department of Clinical Pharmacy and Drug Information Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Husáková, Jitka $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Wosková, Veronika $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Beca, Pavol $u Department of Clinical Pharmacy and Drug Information Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Mrázek, Jakub $u Laboratory of Anaerobic Microbiology, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Tůma, Petr $u Department of Hygiene, Third Faculty of Medicine, Charles University, Prague, Czechia
- 700 1_
- $a Polák, Jan $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czechia
- 700 1_
- $a Dubský, Michal $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Sojáková, Dominika $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Lánská, Věra $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Petrlík, Martin $u Vascular and Internal Medicine Outpatient Clinic, Prague, Czechia
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 15 (20240507), s. 1326179
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38774229 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134117 $b ABA008
- 999 __
- $a ok $b bmc $g 2143657 $s 1225853
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c - $d 1326179 $e 20240507 $i 1664-2392 $m Frontiers in endocrinology $n Front Endocrinol (Lausanne) $x MED00174543
- LZP __
- $a Pubmed-20240725